Skip to main content

Today's Cannabis Economic News (2026-05-15 JST)

News SummaryThis article summarizes the key points by organizing the updates from multiple sources.
Published 2026.05.15Updated 2026.05.15 05:40
Today's Cannabis Economic News (2026-05-15 JST)

While the US Congress is taking action and the use of medical marijuana in hospitals is expanding, the stock market is becoming more selective, and in Europe, medical-oriented business models are coming to the forefront.
In terms of research, quality and safety challenges and advancements in new inspection technologies are progressing simultaneously, creating a situation that continues to influence regulatory costs and market opportunities.

概況

The U.S. House of Representatives passed an amendment allowing veterans-turned-VIP physicians to recommend medical marijuana, and a bill in Louisiana allowing its use in hospitals for terminally ill patients is nearing final passage.
Meanwhile, policy is a mix of progress and setbacks, with the Appropriations Commission including a block clause against federal-level cannabis rescheduling.
In the stock market, hydroponic materials supplier GrowGeneration rose 17.5% from the previous day, while lender AFC Gamma fell 9%, showing a stark contrast between suppliers and lenders.
Europe is clearly shifting towards the "healthcare and sustainability" axis, and the business design capabilities of operators are becoming a watershed factor in evaluations.

Regulation/policy trends

ThemeContent/Impactquantitative information
VA physicians can now recommend physicians (US House of Representatives)An amendment to the VA guidelines that would allow physicians to assist with state medical marijuana program registrations, which was previously prohibited, was passed via audio vote.Reducing the burden of external medical expenses for veteransThis is expected to lead to a decrease in patient acquisition costs.
The FY2027 Military Approvals Act includes amendments. Cost-effectiveness will depend on individual state policies.
Rescheduling prevention clause (U.S. Appropriations Commission)The House Appropriations Committee approved a provision that would prevent the federal government from using funds to implement a marijuana rescheduling program.Uncertainty regarding the Schedule III transition timeline..
The use of funds is prohibited under Section 591 of the SEC.
Strengthening of enforcement against unregulated cannabinoidsThe House Appropriations Committee report cited the DEA and FDA.Addictive cannabinoid productsInstructions were given to strengthen measures for oral, inhaled, and topical use of the drug.
Increased monitoring of distribution outside of state regulations is possible.
Further details will be provided in the draft expenditure report, and specific penalties and enforcement resources will be determined later.
Medical marijuana use in hospitals (Louisiana)Patients with terminal or irreversible diseases smoking in the hospitalvapeIt can be used in other forms. Hospitals are obligated to develop guidelines.
External procurement and administration are the responsibility of the patient/caregiver.In-hospital storage is in patients' locked containers.Limited to.
The committee voted 10-0 and passed the resolution. Emergency and outpatient departments are exempt.
サイケDelix public opinionIn a nationwide survey conducted by UC Berkeley BCSP,Support for regulated therapeutic access has risen significantly..
Support for unregulated access did not grow, and a system with guardrails was preferred.
Analyzing 2025 data compared to 2023 data confirmed a "significant increase" in support.

source:Marijuana Moment (Recommended by VA Doctors),Marijuana Moment (Preventing Rescheduling),Business of Cannabis (Monitoring/Registration of Unregulated Products),Marijuana Moment (Louisiana),Marijuana Moment (BCSP Public Opinion).

Corporate finance, financial statements, and business finance

Companies/TopicsHighlights/Quantitative InformationSuggestion
GrowGeneration (GRWG)The closing price was $1.61, up 17.5% (+$0.24) from the previous day.
Expectations of a resumption of capital investment and a bottoming out of demand for retail materials.
AFC Gamma (AFCG)Sector lenders under pressure; the company is down 9%.
This reflects concerns about widening credit spreads during the rescheduling transition period.
Organization ChartIn a CEO interview, the quarterSales of $59.8 millionMentioning,vapeThe operational challenges of infused pre-rolls will be explained.
Product mix and operational improvements are key.
Village Farms (VFF)International cannabis sales+171% compared to previous year.
In the Netherlands, Q1+448%Sales growth. Increased annual production due to the addition of new facilities.10,000kg(5 times more than before).
There is room for cost reduction through economies of scale. This will provide leverage for the full-scale launch of experimental sales.
“Cannabis 3.0” theoryInvestor Scott Grossman said that the sector isCompany-specific design capabilitiesHe pointed out that they are now at the stage of differentiation, emphasizing the architectural differences between GTI, Trulieve, and Curareaf.
Instead of a mass rise, focus on fundamental analysis and selection.
Safe Harbor Financial (SHFS)After the rescheduling (mitigation of the impact of 280E)Improving cash flowwithLending normalizationThe CEO explains the possibilities.
Expanding credit lines and lowering procurement costs will ease capital constraints.

source:Business of Cannabis (Stock Price),The Dales Report (OGI/VFF Financial Results),cannabisindustrie.nl (VFF Netherlands),The Dales Report (Cannabis 3.0),The Dales Report (SHFS/Finance).

Market/Investment Trends

  • Canadian stocks saw strong momentum in May. While expectations of progress in the US federal government and reports of a rescheduling boosted sentiment, volatility remained high, and technical analysis is recommended.(Marijuana Stocks)
  • According to New Cannabis Ventures, the Q1 cannabis business revenue of the 11 largest companies reporting in US dollars wasThe average growth rate was +31% year-on-year..howeverExcluding Vireo Growth, the result was -0.7%.This suggests weakness in real growth after adjusting for inflation.(NCV/Alan Brochstein, CFA)
  • Individually, as of the closing time of the previous business day.19 stocks declined, 15 stocks rose, and 4 stocks remained unchanged.Overall, the market was somewhat weak, but some MSO stocks attracted attention.(Business of Cannabis)
  • In terms of policy, strengthening monitoring of unregulated cannabinoids,DEA Schedule III registration 60-day windowTwo threads—the rush of state license applications and the current reality—are creating a dichotomy between market expectations and practical realities.(Business of Cannabis)

European Perspective: Structural Transformation for Healthcare and Sustainability

Sasho Stefanoski, CEO of PHCANN International, said that the European market is moving away from imitating the North American model.A unique identity that prioritizes healthcare and sustainability.It was pointed out that this is being established.
As patient literacy improves and physician acceptance increases, the key to success lies not in the speed or volume of expansion, but in long-term healthcare quality and regulatory compliance operations.(Business of Cannabis)

Research, safety, and technology (business impact)

ThemeMain findingsBusiness Implications
The combined use of cannabis and tobacco and the risk of mental illnessIn the high-risk group for psychosis (CHR),Combining cannabis and tobacco increases the risk of developing the disease by approximately three times..
This will impact the cost of warning labels and education for products aimed at young people, as well as the response of insurance providers.(leafie)
CBDHarmful compounds in oilIn an effectiveness-oriented screening of 13 products,Phthalates (DBP/DIBP),Mycotoxin (zearalenone)Identified the following:
Increased costs due to enhanced quality assurance (QA/QC) and raw material/packaging audits.(PubMed)
Novel detection technology: Cannabinoids in urineOptimization of dispersed magnetic SPE with zeolite-immobilized magnetic nanoparticles. THC/CBDQuantify it.
There is room to improve screening efficiency and reduce operating costs in the fields of employment and traffic safety.(PubMed)
Detection of synthetic cannabinoid EG-2201Naphthalimide-based fluorescent probesLOD 0.4μM, 2-second response, high interference resistance.
Useful for on-site inspections by forensic and regulatory authorities, and has a deterrent effect on distribution.(PubMed)
Functional research: CBD/CBGGPx-like activityCBD andCBGThis promotes the redox reaction.CBG suggests an effect similar to ebselen.
Fundamental knowledge for future product differentiation and application development.(PubMed)
Measurement framework for problematic involvementASSIST-basedIndicators of the severity of involvementWe used data from US university students to analyze correlation factors.
This offers insights into the scoring design for public health measures and insurance underwriting.(PubMed)

Progress in production and supply (Netherlands)

business personEquipment and capabilitiesquantitative information
Village Farms (Leli Holland)New facility in Groningen begins operations. 10 cultivation rooms, LEDs, and expanded supply for experimental sales.
annual production10,000kg(Five times the previous amount). Netherlands Q1 sales+448%.(cannabisindustrie.nl)

A simple guide to terminology and mechanisms

Schedule IIIThis refers to drugs classified under U.S. federal drug regulations as having medical uses and a moderate risk of abuse.
Moving to this location is expected to ease Tax Code 280E (non-deductibility of cannabis business expenses), resulting in a lighter tax burden for businesses.
However, the implementation date is uncertain due to the appropriations committee's blocking clause.
An analogy for a field of study (physics):
相転移Therefore, even slight changes in external conditions such as temperature can completely alter the state of a substance.
Even in the cannabis industry, minor adjustments to "external parameters" such as taxation and access to healthcare can have a phase-transition-like impact, significantly altering capital costs and demand structures.

Voices of experts and stakeholders

  • Alan Brochstein, CFA (NCV): Q1 showed a 31% growth on a headline basis, but excluding outliers, it was -0.7%, emphasizing the need to read "what's in the numbers."(NCV)
  • Scott Grossman (Vindicator Capital): The industry is moving towards "Cannabis 3.0." The competition is shifting from licensing and survival to enterprise architecture.(The Dales Report)
  • Terry Mendez (Safe Harbor Financial CEO): With the mitigation of the impact of 280E,Normalization of the lending environmentwithImproving the health of the balance sheetThe possibility of this progressing was pointed out.(The Dales Report)
  • Representative Ilhan Omar: Rescheduling is progress, but I reaffirm the need for comprehensive legalization at the federal level.(Marijuana Moment)

Today's highlights (3 points)

  • Regulatory conflictThe progress towards lifting the ban on recommending VA physicians coexists with the setback of the Appropriations Committee's clause blocking rescheduling. A reassessment of the policy risk premium is necessary.
  • The sorting market is in full swing.The differences between companies are clear, with GRWG soaring, AFCG plummeting, OGI facing operational challenges, and VFF supply expanding. Cash flow and business design capabilities are the evaluation criteria.
  • Upward pressure on QA/QC costsReports of harmful substances being detected in CBD oil and studies on risks to young people suggest increased investment in quality control and regulatory compliance costs. There is also room to improve operational efficiency through the introduction of testing technologies.

Collection List

Share this article

    RANKING

    Choose from popular products

    Top of page